Financials
- Market Capitalization 13.59 M
- Employee 18
- Founded 2016
- CEO N/A
- Website www.in8bio.com
- Headquarter Delaware, United States
- FIGI BBG00XX9K1M2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.53
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4716 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.53 USD | -1.85% | -11.67% | -3.64% | -68.07% | 14.55 M USD | ||
| 4720 | PASG Passage Bio, Inc. - Common Stock | 4.44 USD | -0.45% | -9.76% | -21.69% | -49.77% | 14.24 M USD | ||
| 4732 | LNAI Lunai Bioworks Inc. - Common Stock | 2.98 USD | +5.30% | +8.76% | +12.03% | +92.26% | 13.51 M USD | ||
| 4735 | GTBP GT Biopharma, Inc. - Common Stock | 0.37 USD | -5.13% | -17.78% | -22.92% | -81.86% | 13.34 M USD |